News › Clinical Practice, Industry News, Patient Care

SkinCeuticals Announces Vivace Partnership with Newest In-Office Treatment

October 12, 2020

SkinCeuticals, a leader in advanced skin care technology, has announced the launch of a minimally invasive skin rejuvenation protocol with Vivace Fractional Micro Needle Radio Frequency Treatment featuring SkinCeuticals C E Ferulic.
SkinCeuticals has partnered with Aesthetics Biomedical’s newest generation of FDA-cleared, minimally invasive radiofrequency microneedling technology, Vivace, to give patients visibly brighter, more radiant skin. This non-surgical skin resurfacing procedure improves skin’s radiance and has shown to be effective in alleviating facial wrinkles, fine lines, improving skin texture, overall glow, and tightening and toning the face, neck, hands and body. This treatment is complemented with SkinCeuticals C E Ferulic, a daytime vitamin C serum proven to deliver advanced environmental protection and visible anti-aging results. C E Ferulic has shown a 44% improvement in skin radiance, 36% improvement in the appearance of wrinkles, and 37% increase in skin firmness.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available